Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...

Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with a modest 0.2% move over the past day and a 1.3% gain over the past week, closing at $114.76. Over ...

Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven more by market angst and fear than by any real weaknesses, seems to be a ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories (NYSE:ABT) reported new FreeDM2 trial results on its FreeStyle Libre continuous glucose monitoring system ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.